iRhoms: A Potential Path to More Specific Therapeutic Targeting of Lupus Nephritis
Lupus nephritis (LN) affects 30% to 60% of patients with systemic lupus erythematosus (SLE) and remains an intractable problem. Despite modern immunosuppressive strategies,
